当前位置:首页 - 行情中心 - 新芝生物(920685) - 财务分析 - 现金流量表

新芝生物

(920685)

  

流通市值:7.14亿  总市值:11.90亿
流通股本:5490.39万   总股本:9151.60万

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金40,736,357.63207,006,948.67133,398,690.5182,328,815.9
  收到的税费返还1,543,345.264,334,509.641,970,048.131,619,065.23
  收到其他与经营活动有关的现金2,399,286.423,736,149.084,683,207.082,917,053.45
  经营活动现金流入小计44,678,989.31215,077,607.39140,051,945.7286,864,934.58
  购买商品、接受劳务支付的现金22,246,678.6652,273,011.8937,664,847.9220,757,146.52
  支付给职工以及为职工支付的现金26,158,928.6263,407,048.8150,896,226.1537,702,266.44
  支付的各项税费5,460,116.5322,020,396.5517,136,386.5313,785,611.34
  支付其他与经营活动有关的现金4,068,634.9816,246,049.5211,813,232.078,501,207.8
  经营活动现金流出小计57,934,358.79153,946,506.77117,510,692.6780,746,232.1
  经营活动产生的现金流量净额-13,255,369.4861,131,100.6222,541,253.056,118,702.48
二、投资活动产生的现金流量:
  收回投资收到的现金111,000,000884,500,000820,450,400.4628,450,400.4
  取得投资收益收到的现金997,202.93,861,887.983,227,916.141,965,565.02
  处置固定资产、无形资产和其他长期资产收回的现金净额-540,292.25190,000190,000
  投资活动现金流入小计111,997,202.9888,902,180.23823,868,316.54630,605,965.42
  购建固定资产、无形资产和其他长期资产支付的现金936,990.0238,472,216.4126,881,902.4223,281,930.84
  投资支付的现金76,000,000882,200,000810,966,918.94603,297,107.74
  投资活动现金流出小计76,936,990.02920,672,216.41837,848,821.36626,579,038.58
  投资活动产生的现金流量净额35,060,212.88-31,770,036.18-13,980,504.824,026,926.84
三、筹资活动产生的现金流量:
  分配股利、利润或偿付利息支付的现金5,880,952.3825,045,746.7125,045,746.7125,045,746.71
  其中:子公司支付给少数股东的股利、利润5,880,952.389,047,619.05--
  支付其他与筹资活动有关的现金7,825,286.572,992,132.372,092,705.411,300,587.96
  筹资活动现金流出小计13,706,238.9528,037,879.0827,138,452.1226,346,334.67
  筹资活动产生的现金流量净额-13,706,238.95-28,037,879.08-27,138,452.12-26,346,334.67
四、汇率变动对现金及现金等价物的影响-226,855.21-177,192.74-20,443.69-938.56
五、现金及现金等价物净增加额7,871,749.241,145,992.62-18,598,147.58-16,201,643.91
  加:期初现金及现金等价物余额96,585,915.595,439,922.8895,439,922.8895,439,922.88
  期末现金及现金等价物余额104,457,664.7496,585,915.576,841,775.379,238,278.97
补充资料:
  净利润-43,699,136.64-15,144,602.06
  资产减值准备-3,098,757.73-1,298,986.72
  固定资产和投资性房地产折旧-4,456,342.9-2,162,171.32
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-4,456,342.9-2,162,171.32
  无形资产摊销-1,038,978.46-302,705.92
  长期待摊费用摊销-920,406.77-513,902.35
  处置固定资产、无形资产和其他长期资产的损失--145,904.27--
  固定资产报废损失-204,343.31--
  公允价值变动损失--3,377,216.92--1,598,663.34
  财务费用-344,812.24-37,949.43
  投资损失--1,901,592.31--1,125,535.31
  递延所得税--92,213.46-111,122.34
  其中:递延所得税资产减少--88,010.58-118,925.42
    递延所得税负债增加--4,202.88--7,803.08
  存货的减少--10,294,277.38--4,721,905.06
  经营性应收项目的减少-7,445,434.68-4,219,542.34
  经营性应付项目的增加-12,390,418.74--11,638,030.14
  其他----224,648.43
  现金的期末余额-96,585,915.5-79,238,278.97
  减:现金的期初余额-95,439,922.88-95,439,922.88
  现金及现金等价物的净增加额-1,145,992.62--16,201,643.91
公告日期2026-04-272026-04-272025-10-292025-08-26
审计意见(境内)标准无保留意见
TOP↑